Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Food and Drug Administration (FDA) Pharmacy Compounding Advisory Committee (PCAC), strongly opposing the addition of seven bulk peptide drug substances to the Section 503A Bulk Drug Substances List
Clinical trials found no associated increase in arrhythmias or adverse cardiovascular events
GHK-Cu acts through three main pathways: epigenetic modulation (4,000+ genes, 31.2% of the genome), stimulation of collagen/elastin/GAG synthesis, and copper transport for the activation of antioxidant SOD and wound-healing enzymes
Considering Epithalon or Peptide Therapy
Our central location makes it highly convenient for patients across the greater San Antonio region to access these transformative services
No injectable or systemic human safety data
US$ 27.09
US$ 26.86
US$ 28.22
US$ 25.37
US$ 21.49
